Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

418 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 418 results

Early research (Phase 1)Looking for participantsNCT06600178
What this trial is testing

Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)

Who this might be right for
Angina Patients With Non-obstructive Coronary Artery DiseaseCoronary Microvascular DiseaseCoronary Microvascular Dysfunction (CMD)
University of Virginia 150
Not applicableUnknownNCT04853615
What this trial is testing

SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?

Who this might be right for
SGLT2i Kideny Protection Against Contrast in Diabetic Kidney
Fayoum University 800
Post-approval studies (Phase 4)Study completedNCT07563647
What this trial is testing

Association Between Diastolic Dysfunction and Erectile Dysfunction and the Effect of Tadalafil and SGLT2 Inhibitors on Them in Men With Metabolic Syndrome

Who this might be right for
Erectile DysfunctionLeft Ventricular Diastolic DysfunctionMetabolic Syndrome
Kafrelsheikh University 60
Not applicableStudy completedNCT04151849
What this trial is testing

Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota

Who this might be right for
Type 2 Diabetes
University of Tartu 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07516847
What this trial is testing

Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)Anemia
Seug yun Yoon, MD 37
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435
What this trial is testing

Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

Who this might be right for
Type 2 Diabetes (T2DM)
MaryAnn Banerji 60
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Testing effectiveness (Phase 2)Study completedNCT00297180
What this trial is testing

Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

Who this might be right for
Obesity
GlaxoSmithKline 136
Large-scale testing (Phase 3)Looking for participantsNCT06217302
What this trial is testing

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1+1 more
Alessandro Doria 150
Early research (Phase 1)Study completedNCT03560323
What this trial is testing

Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1

Who this might be right for
Heart FailureType 2 Diabetes Mellitus
The University of Texas Health Science Center at San Antonio 41
Post-approval studies (Phase 4)Not Yet RecruitingNCT07775846
What this trial is testing

QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Kidney Disease
Huijie Zhang 820
Not applicableStudy completedNCT03748810
What this trial is testing

Head-to-head Comparison of Empagliflozin and Dapagliflozin

Who this might be right for
Type2 Diabetes
Chungbuk National University Hospital 600
Testing effectiveness (Phase 2)Study completedNCT03093103
What this trial is testing

Empagliflozin and Renal Oxygenation in Healthy Volunteers

Who this might be right for
Nephropathy
Centre Hospitalier Universitaire Vaudois 45
Not applicableStudy completedNCT04017221
What this trial is testing

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2UrosepsisDiabetic Ketoacidosis+1 more
Canadian Network for Observational Drug Effect Studies, CNODES 1,249,636
Testing effectiveness (Phase 2)Study completedNCT04907214
What this trial is testing

SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot

Who this might be right for
ObesityPre-diabetes
Vanderbilt University Medical Center 29
Post-approval studies (Phase 4)Study completedNCT06026787
What this trial is testing

Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeSodium-Glucose Transporter 2 Inhibitors
Ain Shams University 60
Not applicableLooking for participantsNCT06863532
What this trial is testing

Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial

Who this might be right for
Type 2 Diabetes
Second Affiliated Hospital, Zhejiang University, School of Medicine 80
Not applicableStudy completedNCT05417646
What this trial is testing

Impact of SGLT2 on Glucosuria in HNF1A-MODY

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3Type 2 Diabetes
Steno Diabetes Center Copenhagen 21
Not applicableStudy completedNCT05890131
What this trial is testing

Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy

Who this might be right for
Heart Failure
Morten Schou 5,996
Post-approval studies (Phase 4)UnknownNCT03458715
What this trial is testing

The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin

Who this might be right for
Type2 Diabetes
Mackay Memorial Hospital 120
Next Page